Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Madarosis.

J J Khong1, R J Casson, S C Huilgol

  • 1Oculoplastic and Orbital Unit, Department of Ophthalmology and Visual Science, Royal Adelaide Hospital, University of Adelaide, North Terrace, Adelaide, SA 5000, Australia.

Survey of Ophthalmology
|December 1, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Shining light on CRISPR/Cas9 therapeutics for inherited retinal diseases.

Progress in retinal and eye research·2025
Same author

Outcomes of intubation and endoscopic DCR in functional nasolacrimal duct obstruction.

Rhinology·2022
Same author

Clinico-radiological findings of neuroendocrine tumour metastases to the orbit.

Orbit (Amsterdam, Netherlands)·2021
Same author

Oculoplastic, Orbital, and Lacrimal Care in the Coronavirus Disease 2019 Pandemic: A Shared Experience From Melbourne.

Ophthalmic plastic and reconstructive surgery·2020
Same author

Bisphosphonate-induced orbital inflammation: more common than once thought?

Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·2019
Same author

HIF signalling: The eyes have it.

Experimental cell research·2017
Same journal

Macular telangiectasia masqueraders.

Survey of ophthalmology·2026
Same journal

Utilization of anterior segment optical coherence tomography in childhood glaucoma: A systematic review.

Survey of ophthalmology·2026
Same journal

Peripapillary pachychoroid syndrome: Clinical and imaging features, diagnostic differentiation and therapeutic strategies.

Survey of ophthalmology·2026
Same journal

Prognostic factors and postoperative outcomes in pediatric cataract patients: A systematic review and meta-analysis.

Survey of ophthalmology·2026
Same journal

Predicting the progression of proliferative diabetic retinopathy: Pathophysiology, imaging phenotypes, and determinants of disease persistence despite therapy.

Survey of ophthalmology·2026
Same journal

Comment on "Quantitative imaging for assessing uveitis activity: A comprehensive review".

Survey of ophthalmology·2026
See all related articles

Madarosis, or eyelash loss, can signal serious health issues like infections or tumors. Understanding its causes, whether scarring or non-scarring, is key to diagnosis and treatment.

Area of Science:

  • Ophthalmology
  • Dermatology
  • Internal Medicine

Background:

  • Madarosis (eyelash loss) is a significant clinical sign.
  • It can be associated with various vision and life-threatening conditions.
  • Etiologies range from infections and endocrine disorders to neoplasms and trauma.

Purpose of the Study:

  • To highlight madarosis as a presenting sign of serious conditions.
  • To categorize the pathogenic pathways (scarring vs. non-scarring) and their implications for lash regrowth.
  • To emphasize the importance of clinical history and examination in diagnosing associated disorders.

Main Methods:

  • Review of clinical history and examination findings in patients with madarosis.
  • Categorization of madarosis based on pathogenic pathways.

Related Experiment Videos

  • Analysis of associated conditions, including infections, autoimmune diseases, and malignancies.

    • Main Results:

    • Madarosis presentation can precede diagnosis of conditions like herpes zoster, leprosy, HIV/AIDS, and eyelid tumors.
    • Pathogenic pathways include scarring (permanent loss) and non-scarring (potential regrowth).
    • Differential diagnosis encompasses dermatological, infectious, endocrine, neoplastic, drug-related, congenital, and traumatic causes.

    Conclusions:

    • Madarosis warrants thorough investigation to rule out sight- and life-threatening disorders.
    • Distinguishing between scarring and non-scarring etiologies is crucial for prognosis and management.
    • A systematic approach to clinical evaluation is essential for patients presenting with madarosis.